L. E. Bermudez, Wu, M., and Young, L. S.,
“Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium.”,
Infection and immunity, vol. 63, no. 10, pp. 4099-104, 1995.
L. E. Bermudez, Inderlied, C. B., Kolonoski, P., Petrofsky, M., and Young, L. S.,
“Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice.”,
Antimicrobial agents and chemotherapy, vol. 38, no. 12, pp. 2717-21, 1994.
L. E. Bermudez, Nash, K. A., Petrofsky, M., Young, L. S., and Inderlied, C. B.,
“Effect of ethambutol on emergence of clarithromycin-resistant Mycobacterium avium complex in the beige mouse model.”,
The Journal of infectious diseases, vol. 174, no. 6, pp. 1218-22, 1996.
L. E. Bermudez, Kolonoski, P., Petrofsky, M., Wu, M., Inderlied, C. B., and Young, L. S.,
“Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.”,
The Journal of infectious diseases, vol. 187, no. 12, pp. 1977-80, 2003.
L. E. Bermudez,
“Immunobiology of Mycobacterium avium infection.”,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, vol. 13, no. 11, pp. 1000-6, 1994.